Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
5.59
-0.30 (-5.09%)
May 21, 2026, 3:04 PM CST
SHE:002022 Revenue
Shanghai Kehua Bio-Engineering Co.,Ltd had revenue of 395.10M CNY in the quarter ending March 31, 2026, with 1.86% growth. This brings the company's revenue in the last twelve months to 1.65B, down -3.17% year-over-year. In the year 2025, Shanghai Kehua Bio-Engineering Co.,Ltd had annual revenue of 1.64B, down -6.63%.
Revenue (ttm)
1.65B
Revenue Growth
-3.17%
P/S Ratio
1.79
Revenue / Employee
882.19K
Employees
1,870
Market Cap
2.95B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.64B | -116.71M | -6.63% |
| Dec 31, 2024 | 1.76B | -668.88M | -27.55% |
| Dec 31, 2023 | 2.43B | -4.54B | -65.16% |
| Dec 31, 2022 | 6.97B | 2.12B | 43.58% |
| Jan 1, 2022 | 4.85B | 698.88M | 16.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Canopus Wisdom Medical Technology | 3.94B |
| Guangdong Transtek Medical Electronics | 996.64M |
| Ningbo David Medical Device | 575.66M |
| Anhui Hongyu Wuzhou Medical Manufacturer Co.,LTD. | 454.82M |
| Tellgen | 371.54M |
| Kontour (Xi'an) Medical Technology | 342.27M |
| Zhejiang Tailin BioEngineering Co.,Ltd | 339.54M |
| Beijing Leadman Biochemistry | 317.86M |